- Report
- February 2026
- 331 Pages
Global
From €5124EUR$5,850USD£4,501GBP
- Report
- February 2026
- 246 Pages
Global
From €5124EUR$5,850USD£4,501GBP
- Report
- March 2025
- 181 Pages
Global
From €3941EUR$4,500USD£3,462GBP
- Report
- June 2025
- 215 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- March 2025
- 228 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- January 2026
- 291 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- January 2026
- 277 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- January 2026
- 292 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- January 2026
- 304 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- January 2026
- 290 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- January 2026
- 280 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- January 2026
- 289 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- January 2026
- 276 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- January 2026
- 303 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- August 2025
- 216 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- August 2025
- 220 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- August 2025
- 217 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- August 2025
- 225 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- August 2025
- 215 Pages
Global
From €2190EUR$2,500USD£1,923GBP
- Report
- July 2025
- 198 Pages
Global
From €2190EUR$2,500USD£1,923GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more